GLP-3, 40mg
$240.00
- Product Name: GLP-3
- Sequence: Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
- Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
- Molecular Weight: 4731.33 g/mol
- Research Only: Yes
- Form: Lyophilized Solid
- Purity: >99%
- Storage: Keep refrigerated upon reconstitution
Some COAs may contain redactions of confidential or proprietary information. These redactions do not impact or obscure any analytical data, including compound identity, purity, or test results.
Out of stock
GLP-3, triple receptor agonist (40 mg) – Research Overview
This synthetic peptide is classified as a triple receptor agonist with activity at glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors in controlled laboratory settings.
It is utilized in preclinical and in vitro research to investigate the coordinated effects of multi-receptor activation on metabolic signaling pathways. This compound provides a structured framework for studying energy balance, glucose regulation, and lipid metabolism in models of metabolic dysregulation.
Simultaneous engagement of incretin and glucagon pathways enables researchers to explore receptor cross-talk, hormonal signaling cascades, and downstream metabolic processes under controlled experimental conditions.
Mechanistic Profile
- GLP-1 Receptor Activity
Commonly studied in relation to glucose pathway regulation and appetite signaling mechanisms. - GIP Receptor Modulation
Investigated for its role in nutrient handling, metabolic signaling, and energy balance. - Glucagon Receptor Activity
Explored for its involvement in energy expenditure, lipid oxidation, and systemic metabolic regulation.
Research Applications
This compound is used in laboratory research to support investigation across multiple metabolic endpoints, including:
- Energy Balance and Body Mass Regulation Models
- Glucose Pathway and Insulin Signaling Studies
- Lipid Metabolism and Substrate Utilization Research
- Receptor Interaction and Multi-Pathway Signaling Analysis
Preclinical studies often compare triple-receptor agonist activity to single- and dual-pathway approaches to evaluate differences in signaling behavior, metabolic response patterns, and durability of effects.
Experimental Context
In controlled research models, triple receptor agonist compounds have been investigated for their potential influence on:
- Glucose regulation pathways
- Lipid accumulation and hepatic fat dynamics
- Energy expenditure and metabolic efficiency
- Appetite-related signaling mechanisms
Observed effects are dependent on study design, model system, and dosing parameters, and are not intended to imply clinical outcomes.
GLP-3 is not approved by the U.S. Food and Drug Administration for human use, and its safety, efficacy, and pharmacological profile have not been established in approved FDA clinical trials. It is not intended to diagnose, treat, cure, or prevent any disease.
Lyophilized Peptides
These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage.
Disclaimer: For Research Purposes only
This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research. The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use. Peptides described here are solely for use in structured scientific study by authorized individuals. We advise consulting with research experts, medical practitioners, or legal counsel prior to any decisions about obtaining or utilizing these peptides. The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount. This notice is dynamic and governs all provided content on research peptides.
